Increased frequency of CD4 + CD25 + FoxP3 + circulating regulatory T cells [Treg] in tuberculous patients

CD4 + CD25 + FoxP3 + circulating regulatory T cells [Treg] play a fundamental role in the control of immune responses by down-regulating the function of effector CD4 + or CDS + T cells. Active suppression by Treg might be important in controlling immune responses against Mycobacterium tuberculosis [Mtb]. This study was conducted to evaluate the cellular immune response to Mtb, by evaluation of Treg cells in peripheral blood mononuclear cells [PBMCs] from patients with active pulmonary tuberculosis [PTB], patients with tuberculous pleurisy [TP] and healthy positive PPD persons as control, then evaluation after 6 months of anti-TB therapy, also evaluation of Treg cells in pleural fluid mononuclear cells [PFMCs] from patients with tuberculous pleurisy [TP]. We compared the frequency of CD4 + CD25 + FoxP3 + circulating regulatory T cells [Treg] in 20 patients with active pulmonary TB [PTB], 15 tuberculous pleurisy [TP] and 20 control latent tuberculosis. Treg frequencies in peripheral blood were significantly higher in patients with PTB and TP than in the control group [p < 0.001]. Treg frequencies were significantly higher in pleural effusions than in peripheral blood in the same group [p < 0.001]. Treg frequencies in peripheral blood were significantly decreased after 6 months of anti-TB treatment [p < 0.001]. Immune regulatory mechanisms may limit the immunopathologic condition of infection with M. tuberculosis and suppress cellular immune responses in the host. We investigated the CD4 + CD25 + FoxP3 + circulating regulatory T cells [Treg] in patients with pulmonary tuberculosis, tuberculous pleurisy and latent TB, and the frequencies of CD4 + CD25 + FoxP3 + T-cells after anti-TB therapy. MTB infection is associated with an increase in the frequency of CD4 + CD25 + FoxP3 + Treg in the blood of PTB and TP, in the pleural fluid of TP, decrease in the frequency after anti-TB therapy

Histological and immunohistochemical assessment of the immunological aspect of certain cells in human palatine tonsils

Tonsils contain four specialized lymphoid compartments that together are involved in immune functions. The capacity of tonsillar lymphocytes to counter infections may be altered during one's lifetime. The classification of lymphocytes by CD antigen expression is now widely used in clinical medicine and experimental immunology. The present work was designed to study the distribution of CD4 and CD8 antigen expression in T lymphocytes in human tonsils at different periods of life. Sixty-two tonsillar specimens were obtained from still birth infants and from children aged 1-9 years. Paraffin sections were prepared and stained with H and E and with immunohistochemical stains to demonstrate CD4 and CD8 T lymphocytes. The distribution of these cells in the different components of the tonsils was evaluated with an image analyzer. The obtained data were statistically analyzed using SPSS. There was a significant increase in the distribution of stained CD4 and CD8 T lymphocytes in the interfollicular areas, mantle zones of lymphoid follicles, and partially in the germinal centers of the examined tonsils with the advancement of age. Activated T lymphocytes differentiate into several subtypes, among which are CD4 and CD8 cells. These types of T lymphocytes express surface antigens, which can interact with different foreign pathogens

The critical time of avian leukosis virus subgroup J-mediated immunosuppression during early stage infection in specific pathogen-free chickens

The critical time of avian leukosis virus subgroup J (ALV-J)-mediated immunosuppression was determined by body weight, relative immune organ weight, histopathology, and presence of group specific antigen and antibodies in specific pathogen-free (SPF) chickens. CD4+ and CD8+ cell activity in the spleen, total and differential leukocyte counts in blood, and viral RNA levels in spleen were measured. Significant growth suppression was observed in the two ALV-J-infected groups. A strong immune response by infected groups was present in spleen at 2-weeks-of-age, but after 4-weeks-of-age, the response decreased quickly. The thymus and bursa showed persistent immunosuppression until 4-weeks-of-age. Proliferation of fibroblasts and dendritic cells were observed in immune organs at 4- and 5-weeks-of-age. However, the granulocyte cell number was markedly lower in the infected groups than in the control group. In group 1 (day 1 infection) CD4+ cells increased during the second week but significantly decreased during the fourth week, while group 2 (day 7 infection) showed the opposite effect. Viral RNA increased significantly by the fourth week. These data identify 3~4 weeks post-infection as the key time at which the ALV-J virus exerts its immunosuppressive effects on the host.

Study of the immune effects in hemodialysis patients receiving erythropoietin

Recombinant human erythropoietin [rHuEpo] [Clinical Pathology Department] may affect the human immune system. Partial correction of anemia by erythropoietin improves hemodialysis [HD]-[Immunology Department]. associated immunosuppression. It is not known whether hemoglobin normalization improves immune status further. All in Damanhour National Numerous studies have investigated the immune effects Medical Institute, of recombinant human erythropoietin [rHuEPO] used in the treatment of anemia of ESRD to hematocrits of 28 to 31%, showing improvement in cell-mediated and humoral immunity. The aim of the study: In the present study, we compared prospectively the immune system parameters of hemodialysis [HD] patients who received rHuEPO and were randomized to normal hemoglobin versus anemic hemoglobin. The study protocol was approved in Damanhur National Medical Institute, and patients provided written informed consent. Each patient was followed for 12 months with serum sample obtained at 12 months. During the course of the study, the slope of CD8 cells increased significantly from baseline in the anemic group [P<0.0001], whereas there was no change in the normal hemoglobin group. Our study sought to determine whether the immune system of HD patients with normalized hemoglobin differed from that of HD patients with partially corrected anemia

Immune-regulation in chronic hepatitis B virus infected patients

To assess the percentage of regulatory T cells in peripheral blood of chronic hepatits B [CHB] virus infected patients in comparison with that in healthy controls and to evaluate their suppressive activity on gamma-IFN production by T cells. The percentages of CD4+CD25+ and CD4+CD25+Foxp3+ regulatory T [Treg] cells were quantified in the peripheral blood of 59 chronic hepatitis B patients in comparison with that of 32 controls. And to assess Treg suppressive activity, the percentage of CD4+CD25+Foxp3+Tregs secreting interleukin-10 [IL-10] were evaluated together with the percentage of gamma interferon [gamma-IFN] secreting T cells. This study showed that the percentage of CD4+CD25+Tcells was significantly higher in CHB patients in comparison with healthy controls [mean, 11 +/- 1.7 vs. 36 +/- 4.0 P= 0.007]. A weak positive correlation was observed only between the percentage of CD4+CD25+Foxp3+T cells and serum alanine aminotransferase [ALT] levels [r=0.3, P=0.02]. These findings suggest that Tregs are capable of inhibiting the HBV immune response, which could contribute to persistence of HBV infection. Manipulating these regulatory cells represent an important objective in order to develop new anti-microbial immunotherapies, particularly for chronic infections

Effect of major burn on immunophenotype of peripheral blood T lymphocytes

The immunosuppressive effect of a major burn has been known for many years. However, a complete understanding of the effects of a burn on the immune system remains elusive. Lymphocytes immunophenotype is a reflection of the functional level of immune system. There is little knowledge concerning the expression of HLA-DR on peripheral blood [Pb] T lymphocytes. T lymphocytes of 26 major burn [25-40%] patients were analyzed in 24 hours, 1 week and 2 weeks after burn, using, monoclonal antibodies of CD3, CD4, CD8, CD25 [IL2R,] and HLA-DR by flow cytometry and comparing them with those of26 apparently healthy donors. There was statistically significant reduction in absolute number of CD3 [p<0.0001], CD4/CD8 ratio [p=0.01] in the first 24 h in comparison with controls. CD25 [IL2R] shows insignificant upregulation on T lymphocytes after burn with significant upregulation of HLA-DR. The absolute number of CD3[+] cells began to increase after 2 weeks [p=0.03]. but still reduced than controls [p=0. 08,]. CD4/CD8 ratio was more or less as healthy control after 2 weeks. Upregulation of CD25 was insignificantly increased and that of HLA-DR were marked increased after 2 weeks. The absolute number CD25 and HLA-DR[+] T lymphocyte subsets all over the time of the study are low than controls except that of HLA-DR[+] T lymphocytes after 2 weeks [p=0.009]. The data obtained suggest persistent activation of T lymphocytes 2 weeks post major burns. HLA-DR expression can reflect post burn lymphocyte activation

Flow cytometric study of T-cell subsets and costimulatory molecules in clinical forms of human schistosoma mansoni chronic infection

Helminthic parasites cause widespread, persistent infections in humans. Schistosomiasis mansoni infected patients being in a chronic immune-activation state enabled us to investigate the effects of such immune activation on immune responses. We performed by flow cytometry aphenotypic analysis of peripheral blood T lymphocytes from 64 Schistosoma mansoni infected patients, in different clinical forms of the chronic disease. The main findings in the patient group in comparison with the non-infected controls were: [i] decreased CD3, CD4 and CD8 lymphocyte counts; [ii] elevated levels of activated T cells [CD4 expressing HLA-DR]; [iii] decreased numbers of CD28+ CD8+ lymphocytes. These findings support the notion that chronic helminthic infections cause persistent immune activation that result in hyporesponsiveness and anergy. Such impaired immune functions may diminish the capacity of these individuals to cope with infections and to generate cellular protective immunity after vaccination

Dysregulation of immune system in diabetic child

Diabetes is a chronic disease associated with selective destruction of the pancreatic B-cells. The exact etiology of the disease is unclear; however, insulin deficiency results from autoimmune destruction of B-cells. The appearance of auto antibodies to beta cell antigen, such as those against the 65-KDA isoform of glutamic acid decarboxylase GAD65 and the protein tyrosine phosphates in the peripheral circulation is a predictive sign of clinical disease in non diabetic individuals. Although GAD65 and IA-2 [insulin auto antibodies] may not be directly involved in the pathogenic processes in beta-cell destruction. They are good markers in assessing the risk of disease manifestation. This study aimed to evaluate GAD65 [glutamic acid decarboxylase] and ICA [islet cell auto antibodies] and IA-2 [insulin auto antibodies] auto antibodies as a disease markers and their relationship to certain residual beta cell function and glycemic control in type I diabetes and risk group, and assess the relation between CD4 [+] CD25 [+] [T-regulatory cells] and immune mediated diabetes. This study was conducted on 50 subjects randomly selected from those attending pediatrics outpatients clinics in the period of 2008. The subjects were classified into 3 groups: 1-Group A [patient group]: This group included 20 patients diagnosed as type I DM according to WHO classifications. Their ages ranging from 3-16 years with a mean age of 10.6 +/- 4.0. They were 11 males and 9 females. 2-Group B: [Risk group]: included 20 sibling of diabetic [type I DM] father, mother or both. They were 9 females and 11 males their ages ranging from 18 years to 25 years with a mean of age 21 +/- 2.5. 3-Group C: Control group, included 10 healthy children; they were 5 females and 5 males, their ages ranging from 5-16 years with a mean age of 10.8 +/- 2.8, with no family history of diabetes mellitus. All subjects are subjected to: Complete history taking, Full clinical examination, Complete blood picture, Glycosylated Hb using ion-exchane chromatography, C-peptide of insulin by-ELISA, determination of GAD 65, ICA and IA-2 auto antibodies by ELISA technique, Flowcytometric measurement of the expression of the CD4 [+] /CD25 [+] of T-regulatory cell. The most frequently encountered antibody in children group was GAD65 in 60% of cases, followed by ICA, 40%. When taken together, both GAD65 and ICA were detected in 30%. IA-2 was detectable only in 30% of cases. When both GAD65 and IA-2 were taken together, they were detected in 25% of cases also ICA and IA-2 were detected in 15% of cases. When GAD, ICA and IA-2 were taken together, they were detectable in 5% of cases. The most frequently encountered antibody in risk group was ICA in 15% of cases, followed by GAD, in 10%. When taken together, both GAD65 and ICA were detected in 10%. IA-2 was detectable only in 10% of cases. When both GAD65 and IA-2 were taken together. they were detected in 5% of cases also ICA and IA-2 were detected in 15% of cases. When GAD, ICA and IA-2 were taken together, they were detectable in 5% of cases. There was highly significant difference between 3 groups for prevalence of GAD65 autoantibody [p<0.001] and significant difference between 3 groups for prevalence of ICA autoantibody [p<0.005] and significant difference between 3 groups for prevalence of IA-2 autoantibody [p<0.003]. There were highly significant differences in the level of fasting C-peptide of insulin between patient and control groups. [p value<0.001]. There were significant difference between level of fasting Cpeptide and single and multiple autoantibody positivity [p<0.05]. In the children group the mean and SD of the percentage of CD4 [+] CD25 [+] from CD4 cells were 0.96, 0.46 respectively. In the control group the mean and SD of the percentage of CD4 [+] CD25 [+] from CD4 cells were 2.85, 0.92 respectively. The difference between control and study group according to the mean and SD of the percentage of CD4 [+] CD25 [+] from CD4 cells was statistically highly significant [p<0.001]. In the Risk group the mean and SD of the percentage of CD4 [+] CD25 [+] from CD4 cells were 0.99, 0.7 respectively. In the control group the mean and SD of the percentage of CD4 [+] CD25 [+] from CD4 cells were 2.96, 0.62 respectively. The difference between control and risk group according to the mean and SD of the percentage of CD4 [+] CD25 [+] from CD4 cells was statistically non significant. There was highly sig relation [p<0.001] between percent of CD4 [+] CD25 [+] out of CD4 cells and the presence and absence of auto antibodies in the children group. There was no sig relation between percent of CD4 [+] CD25 [+] out of CD4 cells and the presence and absence of auto antibodies in the in risk group. At the time of diagnosis almost all patients with type I diabetes have auto antibodies that are reactive to islet antigens and auto antibodies GAD, ICA, lA-2 are of' value for predicting IDDM in sibling of diabetic parents type I also CD4[+] CD25[+]T-regulatory cells actively suppress activation of the immune system and prevent pathological self-reactivity

Role of specific clone of lymphocytes, [CD4[+] and CD8[+]] and the sympathetic activity in pathophysiology of altered immunity in ischemic stroke

Ischemic stroke is one of the major causes of high morbidity and mortality allover the world. The understanding of the pathophysiology of post-ischemic immune response is very limited. Cerebral ischemic stroke affects the normally well-balanced interplay of the 2 super systems: the nervous and the immune system. T-cell lymphocytes, [CD4[-], CD8[-]], may contribute to altered immunity associated with stroke. Increased sympathetic activity during ischemic stroke may have a role in altered lymphocytes function. The present study investigated the contribution of CD4[-] and CD8[-] and the sympathetic activity in altered immunity in ischemic stroke. Determination of CD4[-] and CD8[-] percentage in patient's blood was done by flowcytometry. Evaluation of sympathetic activity done by measuring urinary vanilmandelic acid [VMA] levels by spectrophotometry. The study also correlated the changes of these parameters with specific clinical and diagnostic variables in stroke. The study showed that CD4[-] and CDS percentage were significantly lower [p<0.001], while CD4[-] /CD8[-] ratio was significantly higher [p<0.001] in patients than controls. There was also significantly increased [p<0.001] mean urinary VMA excretion levels [mg/day] in patients compared to control group. Significantly lower CD4[-]% and CD4[-] /CD8[-] ratio and higher CD8[-]% were found in patients with recurrent stroke or history of transient ischemic attacks, progressive strokes and large size of infarction in comparison to other comparable patients. The study indicated that patients with ischemic strokes may have altered immunity and sympathetic over-activity which may be one of the mechanisms by which modulation of immune response can be induced after stroke. This brain-immune interaction after stroke may have protective, destructive, or regenerative effects in the brain, therefore the development of therapeutic strategies is not straightforward, and must take all these factors into consideration

Correlation between clinical features and degree of immunosuppression in HIV infected children.

We conducted this study to find out correlation of CD4% with clinical status in 102 HIV infected antiretroviral naive children. Mean age of presentation was 4.8 years. Perinatal transmission was the commonest mode of transmission (94%). Fever (53%), chronic diarrhea (36%), and cough (29%) were the commonest presenting symptoms. Protein energy malnutrition was seen in 56.7% of children. 33.3% children were asymptomatic, whereas 45.1% were in WHO clinical stages III and IV at the time of presentation. The most common opportunistic infection was tuberculosis. CD4% correlated significantly with the deterioration of the WHO clinical stages (P<0.01) and increasing grades of protein energy malnutrition (P< 0.05).

Mycobacterium tuberculosis infection of the lungs: CD[+4] T cells and CD[+8] T cells in peripheral blood and their relation to disease outcome

To determine the frequency of CD[+4] and CD[+8] T-cells in peripheral blood [Pb] in the patients with Mycobacterium tuberculosis infection of the lungs and to assess their roles in disease recovery. Flow cytometric analysis of the Pb from 41 patients with active pulmonary tuberculosis and 20 healthy individuals as controls for determination the frequency of CD[+4] and CD[+8] T-cells in Pb. the frequency of CD[+4] and CD[+8] T-cells in Pb from patients with pulmonary tuberculosis was higher than controls [p<0.001 and 0.05 respectively]. The frequency of CD[+4] T-cells was higher than CD[+8] T-cells in Pb of pulmonary tuberculosis patients. The rate of recovery from active pulmonary tuberculosis was inversely related to the frequency of CD[+4] and CD[+8] T-cells being higher in SR, but less in RR and IR. More CD[+8] T-cells producing IFN-y, while more CD[+4] T-cells producing IL-10. there was a higher frequency of CD[+4] T cells in Pb of active pulmonary tuberculosis. The recovery from this disease requires fine balance between CD[+4] c CD[+8] T cells in Pb

Cell-mediated immunity in recent-onset type 1 diabetic children

The ability to suppress an immune response makes regulatory T-cells [T-reg] an attractive candidate as a novel therapeutic agent for treating autoimmune diseases. The mechanisms involved in maintenance of peripheral tolerance include a specialized subset of regulatory-T-cells [T-reg] within the T-cell population. The CD4[+] CD25[+] T-cells may be, important in modulating the risk for autoimmunity. Auto-reactive cytotoxic-cells recognize peptide epitopes displayed on the beta cells surface in the context of HLA class] molecules. A population of CD8[+] regulatory T-cells characterized by expression of CD25 and FOXP3 have been identified and induced in the human peripheral blood cells. The regulatory activity of these cells is on autologous, antigen-reactive CD4[+] T-cells in a cell contact-dependent manner. These findings provide an evidence for a new mechanism for induction of immune regulation in human. This study was aiming to assess the cellular immune parameters including the percentage of CD4[+], CD8[+], CD4[+]/CD8[+] ratio,CD4[+]CD25[+], CD8[+] CD25[+] lymphocytes, which may have its application in developing immune therapy based tools for halting disease progression. This study was conducted on 20 children of recent onset type 1 diabetes [disease duration 0.05] between the two groups. A significant inverse correlation was found between CD4[+] CD25[+] T-cells and HbA1c percentage among patients group [p<0.05].Also a significant difference in the percentage of CD4[+] CD25[+] T-cells was found when patients with HbA1c<8%w ere compared to those with HbA1c >/= 8% [the latter group had significantly lower percentage of CD4[+] CD8[+] T-cells]. Type 1 diabetes is characterised at its onset by a lowered percentage of CD8[+] and CD8[+] CD25[+] T-cells in peripheral blood, a normal percentage of CD4[+] and CD4[+] CD25[+] T-cells. There may be an inverse correlation between percentage of CD4[+] CD25[+] T-cells at disease onset and HbA1c level after three months. These data support the hypothesis that a defect in function or deficiency in number of T-regulatory cells may affect the pathogenesis of type 1 diabetes

study on the prevalence of cryptosporidium in HIV positive patients

AIDS is acquired by infection with HIV [human immuno-deficiency virus]. It leaves the host susceptible to malignant and unusual infections especially opportunistic ones. Most of AIDS patients infected with opportunistic parasitic infections die because of chronic diarrhea and deaths due to Cryptosporidium diarrhea in AIDS patients are considerable in the recent two decades. The aim of this study is to find Cryptosporidium parasite in AIDS patients referring to the center of Diseases consultation in Kermanshah province and to determine the frequency of infection in those patients. In this study stool and blood samples were collected from 75 AIDS patients referring regularly to the Center of Diseases Consultation in Kermanshah and the gathered information were filled in the questionnaires together with their personal information regarding their names, sex and etc. Stool samples were tested using direct and formalin ether methods and then the smears that were dyed using modified acid fast staining were examined. Peripheral blood samples were used to determine the CD4 counts. The results showed that the frequency of infection with Cryptosporidium in AIDS patients was 26.7% [20 cases]. According to the study, as the number of CD4 decreased in the patients, the probability of infection with opportunistic parasites increased and increase in the number CD4 that is normally accompanied with strengthening the body immune system resulted in the decrease in the frequency of infection with Cryptosporidium

Intracellular IL-5 expression by peripheral blood CD4[+] and CD8[+] T-cells in atopic and non-atopic asthma

There is evidence of CD8[+] and CD4[+] peripheral blood T cell activation in childhood atopic asthma. However, the immunopathology of non-atopic asthma in children remains unclear. We sought to investigate the intracellular IL-5 expression by peripheral blood CD4[+] and CD8[+] T cells in atopic and non-atopic asthmatic children in relation to asthma grading and severity of exacerbation, as well as is possible correlation to various inflammatory markers of asthma. The study comprised 35 atopic and 35 non-atopic asthmatic children enrolled during activity and 30 clinically healthy children. They were subjected to flow cytometric assessment of intracellular IL-5 expression in CD4[+] and CD8[+] T cell subsets as well as absolute eosinophil count, serum total IgE, eosinophil cationic protein [ECP], and urinary Leukotriene E4 [LTE4] estimation. Asthmatic children compiled all together and the atopic group showed highly significant increase in absolute eosinophil count, IgE% from high normal for age, serum ECP, urinary LTE4 / creatinine ratio, intracellular CD4[+] IL5, and CD8[+] IL5 T cell numbers as compared to the control group. Similar results were observed between the non-atopic asthmatic children and the control group. When the atopic and non-atopic asthmatic children were compared, the former group showed significantly higher values of all study parameters except the urinary LTE4, urinary creatinine ratio, and CD8[+] IL5 frequency. CD4[+] IL5 T cell number correlated positively with the absolute eosinophil count, IgE% and serum eosinophil cationic protein among the 70 asthmatic patients. Stepwise multi-regression analysis revealed CD4[+] IL-5 frequency to be an inverse independent variable for asthma exacerbation. Likewise, IL-5 production, either CD4[+] or CD8[+] T cells was an inverse independent variable for grading of asthma severity. Both CD8[+] and CD4[+] T cells contribute to the IL-5 production in asthmatic children whether atopic or non-atopic during disease activity. CD4[+] T cell IL-5 frequency estimation could be a useful marker for asthma exacerbation severity and both CD4[+] and CD8[+] T cell IL-5 frequencies might serve as markers for asthma grading

Flowcytometric analysis of T-lymphocytes and serum tumour necrosis factor alpha [TNF- alpha] levels in schistosoma mansoni patients

Analysis of T-lymphocytes by flowcytometry, estimation of serum TNF-alpha level by solid phase enzyme amplified sensitivity immunoassay [EASIA] and IHAT were done for chronic schistosomiasis mansoni patients without hepatic fibrosis, with hepatosplenomegaly and 20 healthy controls. The sensitivity and specificity of IHAT in schistosomiasis mansoni were 85% and 90% respectively. Chronic schistosomiasis mansoni patients showed increase in CD8% [27.3 +/- 5.3] and decrease in CD4% [44.2 +/- 4.68]. Hepatosplenomegaly cases showed increase in CD4% [46.5 +/- 4.1] and decrease in CD8% [23.2 +/- 2.18]. Serum level of TNF-alpha was significantly higher in cases with hepatosplenomegaly compared to either cases of chronic schistosomiasis mansoni or controls. No significant difference was between chronic schistosomiasis mansoni patients and controls. A correlation between hepatosplenomegaly and increase of CD4 and/or decrease of CD8 and significant high level of TNF-alpha indicated TNF-alpha role in granuloma formation

T lymphocyte activation and expression of costimulatory molecules in intestinal Ascariasis

This study was carried on 48 patient with Ascriasis and 12 cross matched healthy control persons. All the studied cases were submitted to flow cytometric analysis of peripheral blood mononuclear cells using monoclonal antibodies against CD3, CD4, CD8, CD28, HLA-DR. In this study, there was a significant decrease in CD3, CD4 and expression of costimulatory molecule CD28 on CD8 T lymphocytes but the decrease in CD8 T lymphocytes was insignificant, while the activation marker HLA-DR expression on CD4 T lymphocytes was increased

T lymphocyte activation and expression of costimulatory molecules in filarial elephantiasis

This study was carried in 48 patients with positive blood films for W. bancrofti microfilaria and 12 cross matched healthy control persons. All the studied cases were submitted to flow cytometric analysis of peripheral blood mononuclear cells using monoclonal antibodies against CD3, CD4, CD8, CD28, HLA-DR. In this study, there was a significant decrease in CD3 and CD4 T lymphocytes but the changes in CD8 T cells and CD28 expression on CD8 T lymphocytes was insignificant while the activation marker HLA-DR expression on CD4 T lymphocytes was increased

T-lymphocytes activation and expression of costimulatory molecules in human toxoplasmosis during pregnancy

The study was carried on 48 pregnant patients with positive sera for Toxoplasma antibodies [IgG, IgM] and 12 cross matched healthy control pregnant women. All studied cases were submitted to flow cytometric analysis of peripheral blood mononuclear cells [PBMNCs]; using monoclonal antibodies [MAbs] against CD3, CD4, CD8, CD28 and HLA-DR. Results revealed that, there was a significant decrease in CD4 and the expression of co stimulatory molecule CD28 on CD8 T lymphocytes, while the activation marker HLA-DR expression on CD4 T lymphocytes was significantly increased, but the changes in CD3 and CD8 T lymphocytes were insignificant

Relation between T lymphocytes activities and the intensity of schistosoma mansoni infection

This study was done on 60 schistosome patients and 12 cross matched healthy control persons. The schistosome patients were classified on the bases of intensity of infection into: 22 patients with light infection [one to 100 eggs/gm stool], 24 patients with moderate infection [101- 400 eggs/gm stool], 14 patients with heavy infection [>400 eggs/gm stool]. All the studied cases were submitted to flow cytometric analysis of peripheral blood mononuclear cells using monoclonal antibodies against CD3, CD4, CD8, CD28, HLA-DR. It was found that there was a significant decrease in CD3, CD4 and the expression of costimulatory molecule CD28 on CD8 T lymphocytes, while CD8 T lymphocytes and the activation marker HLA-DR expression on CD4 T lymphocytes were increased. These changes were more obvious with the increase in intensity of infection

Continuous ambulatory peritoneal dialysis improves both the number and memory function of CD4 T cells in uremic patients.

Cell-mediated immune response (CMIR) was studied in 16 ESRD (end-stage renal disease) patients prior to and after 6 months of treatment with CAPD (continuous ambulatory peritoneal dialysis). Quantitative assessment of the CMI system showed that the mean values of number and percentage of total lymphocyte count, CD4, CD8, and CD4/CD8 in ESRD patients were lower than in the normal population. Such values, however, were significantly increased after 6 months of CAPD treatment. To determine qualitative function of the CMI system, both in vitro (PHA stimulation test) and in vivo (multi CMI skin test) tests were examined. There were no significant changes in the results of PHA stimulation test after 6 months of CAPD treatment. In multi CMI skin test, the number of patients converting from negative to positive result was obviously noted following CAPD therapy for 6 months. In conclusion, both quantitative and qualitative CMI impairment existing in ESRD patients could be corrected, although not completely, by 6-month CAPD treatment.